Postmarketing surveillance--lack of vigilance, lack of trust

JAMA. 2004 Dec 1;292(21):2647-50. doi: 10.1001/jama.292.21.2647. Epub 2004 Nov 22.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Conflict of Interest
  • Drug Approval*
  • Drug Industry*
  • Product Surveillance, Postmarketing
  • United States
  • United States Food and Drug Administration*